Indoleamine 2,3-dioxygenase expression and overall survival in patients diagnosed with breast cancer in Pakistan

BACKGROUND: Immune dysfunction in breast cancer patients is well established. Indoleamine 2,3-dioxygenase (IDO) is an immunosuppressive enzyme that is linked with progression of cancer. IDO is overexpressed in triple-negative breast cancer (TNBC) cases. MATERIALS AND METHODS: We conducted the first...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Cancer Manag Res
Prif Awduron: Asghar, Kashif, Loya, Asif, Rana, Iftikhar Ali, Tahseen, Muhammad, Ishaq, Muhammad, Farooq, Asim, Bakar, Muhammad Abu, Masood, Iqra
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Dove Medical Press 2019
Pynciau:
Original Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6322492/
https://ncbi.nlm.nih.gov/pubmed/30655699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S184221
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg